Funder
American Cancer Society
National Cancer Institute
South Carolina Center of Economic Excellence
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, et al. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014;15(13):e594–605.
2. Yang YT, Chen B, Bennett CL. Biosimilars—curb your enthusiasm. JAMA Oncol. 2017;3(11):1467–8.
3. Mulcahy AW, Hlavka JP, Case SR. Biosimilar cost savings in the United States: initial experience and future potential. Rand Health Q. 2018;7(4):3.
4. Chen B, Yang YT, Bennett CL. Challenges to biosimilar substitution. Jama. 2017;318(12):1186.
5. Chen B, Yang TY, Bennett C. Reply—Friction in the path to use of biosimilar drugs. N Engl J Med. 2018;378(22):2148.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献